Esomeprazole in PPI Failures - IMPROVE

NCT00272701 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Esomeprazole
DRUG: Other PPI marketed in Sweden

Sponsor

AstraZeneca